1063P Differential tumor responses are a poor prognostic factor in patients receiving immune checkpoint inhibitors von Tozzi, C., Ligero, M., Antolin, A., Atlagich, L.M., Staikoglou, N., Bernatowicz, K., Vieito Villar, M., Alonso, G., Galvao, V., Braña, I., Oberoi, A., Saavedra Santa Gadea, O., Muñoz Couselo, E., Garralda, E., Perez Lopez, R.

Volltext